Press "Enter" to skip to content

McSally Endorses Grassley-Wyden Bipartisan Prescription Drug Bill

February 11,2020

Washington – Sen. Martha McSally (R-Ariz.) today endorsed
Senate Finance Committee Chairman Chuck Grassley’s (R-Iowa) bipartisan Prescription
Drug Pricing Reduction Act
, growing the ranks of Senate Republican
support. Other Senate Republicans are expected to announce their support for
the bill in the coming days.

“Senator
McSally is a leader in the fight to lower prescription drug prices. By taking
on Big Pharma and putting her constituents first, Senator McSally has shown
that she doesn’t just talk the talk—she walks the walk,” Grassley said.
“The Prescription Drug Pricing Reduction Act would lower premiums, cap
out-of-pocket expenses and rein in the skyrocketing costs of prescription
medicines. I was glad to be able to work with Senator McSally on several
provisions in this bipartisan bill that has earned the endorsement of President
Trump and AARP.”

“As
I travel around the state, the number one issue on the top of Arizonans’ minds
is the rising cost of prescription drugs,” McSally said. “We are at a
point where our seniors are forced to choose between buying groceries and
buying a lifesaving prescription. Parents are forced to choose between paying
rent and buying insulin for their child. I’m supporting Senator Grassley’s
bipartisan legislation to hold pharmaceutical companies accountable for their
drug costs and ensure that Arizonans are getting the best possible deal for
medicine they need.”

Last
week, in his State of the Union address, President Donald Trump called on
Congress to pass bipartisan prescription drug pricing legislation and recognized
Grassley’s leadership on the issue. Grassley’s and Ranking Member Ron Wyden’s
(D-Ore.) legislation is the only significant, bipartisan bill in Congress to
lower drug costs. Vice President Pence also
endorsed
their bill last week.



Go to Source
Author:

%d bloggers like this: